SCHEMBL10078044

SCHEMBL10078044

NCNN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660275 0.69
SCHEMBL466511 0.64
SCHEMBL15494266 0.64
SCHEMBL4169631 0.62
SCHEMBL4609598 0.62
SCHEMBL17265927 0.62
Ethylenediamine SCHEMBL8121893 0.61 CA12 (0.47)
Bromide SCHEMBL31050231 0.61
SCHEMBL18296056 0.59
SCHEMBL563507 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322785-A1 ADENOSINE A2A AND A2B RECEPTOR DUAL ANTAGONISTS FOR IMMUNO-ONCOLOGY MERCK SHARP & DOHME LLC (US) 2023-10-12 US disclosed
EP-3555244-B1 POLYMERS AS DIESEL FUEL ADDITIVES FOR DIRECT INJECTION DIESEL ENGINES BASF SE (DE) 2023-05-31 EP disclosed
WO-2021097240-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2021-05-20 WO disclosed
WO-2020154571-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2020-07-30 WO disclosed
WO-2019183587-A1 COMPOUNDS AND USES THEREOF YUMANITY THERAPEUTICS, INC. (US) 2019-09-26 WO disclosed
US-20170313595-A1 VANADIUM OXIDE FILM AND PROCESS FOR PRODUCING SAME NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2017-11-02 US disclosed
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 EP disclosed
EP-3141252-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION Vertex Pharmaceuticals Inc. (US) 2017-03-15 EP disclosed
US-9512442-B2 Resistance gene and uses thereof THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED (NZ) 2016-12-06 US disclosed
US-9459213-B2 Method of detecting nucleic acids, method of optically observing sample and fluorescent substance SONY CORPORATION (JP) 2016-10-04 US disclosed
US-20100160312-A1 Substituted Pyridone Compounds and Methods of Use AMGEN INC. (US) 2010-06-24 US disclosed
US-7700607-B2 Substituted pyridone compounds and methods of use AMGEN INC. 2010-04-20 US disclosed
US-20080249090-A1 Substituted pyridone compounds and methods of use AMGEN INC. (US) 2008-10-09 US disclosed
US-7320714-B2 High surface area porous aluminum electrode in electrolytic capacitors using solid freeform fabrication INTEL CORPORATION (US) 2008-01-22 US disclosed
US-20070259220-A1 Hydrogen storage, distribution, and recovery system REDMOND SCOTT D 2007-11-08 US disclosed
US-20070224663-A1 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods HUMAN GENOME SCIENCES, INC. (US) 2007-09-27 US disclosed
US-20070185324-A1 Nitrogen-containing bicyclic heteroaryl compounds and methods of use AMGEN INC. 2007-08-09 US disclosed
EP-1767148-A1 MAGNETIC RESONANCE IMAGING DEVICE AND MAINTENANCE METHOD THEREFOR Hitachi Medical Corporation (JP) 2007-03-28 EP disclosed
US-20070054916-A1 Aryl nitrogen-containing bicyclic compounds and methods of use AMGEN INC. 2007-03-08 US disclosed
US-20070042439-A1 Porphyrin compound containing biotinyl group and use thereof RIKEN 2007-02-22 US disclosed